MAPT and Alzheimer disease: Recent multimodal imaging studies—integrating molecular imaging using Aβ- and tau-PET with functional modalities such as MEG, EEG, and fMRI—have demonstrated distinct network-level abnormalities associated with AD proteinopathy.